Products
Platform
Research
Market
Learn
Aurobindo Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 8,406.29 | 7,973.44 | 8,516.93 | 8,135.81 | 7,932.07 |
| Other Income Qtr Cr | 120.59 | 105.30 | 134.81 | 157.29 | 136.00 |
| Operating Revenues Qtr | 8,285.70 | 7,868.14 | 8,382.12 | 7,978.52 | 7,796.07 |
Loading chart... | |||||
Operating Expenses Qtr | 6,607.60 | 6,265.11 | 6,590.20 | 6,400.54 | 6,229.93 |
Operating Profit Qtr | 1,678.10 | 1,603.03 | 1,791.92 | 1,577.98 | 1,566.14 |
EBITDA Qtr Cr | 1,798.69 | 1,708.33 | 1,926.73 | 1,735.27 | 1,702.14 |
Depreciation Qtr | 429.19 | 405.70 | 444.43 | 418.53 | 382.28 |
Net Profit Qtr | 848.45 | 824.75 | 903.47 | 845.81 | 817.38 |
Basic EPS Qtr | 14.61 | 14.20 | 15.56 | 14.56 | 14.00 |
Open Demat Account
Open Demat Account